Empowering appropriate antimicrobial use with rapid diagnostics.

OUR MISSION

The misuse of antibiotics has created a huge global health crisis. The Test Target Treat™ initiative from Alere empowers healthcare professionals to make targeted treatment decisions sooner with rapid diagnostics - reducing inappropriate antimicrobial use and the spread of resistance.

1.0_TTT_dividerbar_440

LATEST NEWS

Review on Antimicrobial Resistance recognises rapid diagnostics as integral to the AMR Global Strategy

Review on Antimicrobial Resistance recognises rapid diagnostics as integral to the AMR Global Strategy

In July 2014, the UK Government commissioned the Review on Antimicrobial Resistance… Read More

What to expect from Alere at ECCMID 2016

What to expect from Alere at ECCMID 2016

Alere is pleased to once again be attending the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam this year from April 9 -12… Read More

GP practice wins Innovation Challenge award for use of Alere Afinion CRP

GP practice wins Innovation Challenge award for use of Alere Afinion CRP

The NHS Innovation Challenge Prizes took place on 28 January 2016. The challenge seeks to encourage, recognize and reward front line innovation… Read More

Alere among 85 companies to sign Declaration Combating Antimicrobial Resistance in Davos

Alere among 85 companies to sign Declaration Combating Antimicrobial Resistance in Davos

The Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial… Read More

RAPID DIAGNOSTIC TESTING

A comprehensive set of diagnotic information, empowering a shift  in prescribing behavior away from the over-use of antibiotics.

1.0_TTT_dividerbar_440
Contact

WANT TO LEARN MORE?

Register for our monthly Test Target Treat e-newsletter alerting you to new educational tools.